| Ticker Details |
|
Invivyd, Inc.
|
| IPO Date: |
August 6, 2022 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$293.73M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.09 | 5.82%
|
| Avg Daily Range (30 D): |
$0.03 | 4.49%
|
| Avg Daily Range (90 D): |
$0.05 | 4.77%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.66M |
| Avg Daily Volume (30 D): |
2.91M |
| Avg Daily Volume (90 D): |
3.02M |
| Trade Size |
| Avg Trade Size (Sh.): |
325 |
| Avg Trade Size (Sh.) (30 D): |
217 |
| Avg Trade Size (Sh.) (90 D): |
248 |
| Institutional Trades |
| Total Institutional Trades: |
118 |
| Avg Institutional Trade: |
$2.42M |
| Avg Institutional Trade (30 D): |
$5.11M |
| Avg Institutional Trade (90 D): |
$2.35M |
| Avg Institutional Trade Volume: |
1.41M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.72M |
| Avg Closing Trade (30 D): |
$17.81M |
| Avg Closing Trade (90 D): |
$6.95M |
| Avg Closing Volume: |
2.72M |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-.14
|
$-.13
|
$
|
|
Diluted EPS
|
$-.14
|
$-.13
|
$
|
|
Revenue
|
$14.29M
|
$13.74M
|
$17.21M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-44.39M
|
$-41.4M
|
$-11.07M
|
|
Operating Income / Loss
|
$-45.82M
|
$-43.14M
|
$-12.56M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-24.07M
|
$-42.54M
|
$141.72M
|
|
PE Ratio
|
|
|
|
|
|
|